28 companies under lens for wrongly claiming services export sops
MUMBAI: The Directorate of Revenue Intelligence (DRI) has begun investigations into 28 companies that have wrongly claimed services export benefits, according to the agency, which has issued notices to them.…
Temasek in final talks to acquire 30-35% stake in AHH for $100 m
Singapore state-owned investment company Temasek Holdings is in the final stages of discussions to acquire a minority stake in Asia Healthcare Holdings, a healthcare platform set up by US-based private…
Pfizer wins appeal against UK fine for epilepsy drug price hike
LONDON, – Pfizer Inc and Flynn Pharma won an appeal on Thursday against fines totalling nearly 90 million pounds ($120 million) imposed in 2016 for ramping up the cost of…
J&J gets $2.7 billion offer for sterilization unit from Fortive
Johnson & Johnson said on Wednesday that Fortive Corp had offered to buy its medical sterilization unit for about $2.7 billion in cash. J&J has been reviewing its portfolio of…
NPPA’s drug price fixing power to be curbed
NEW DELHI: In an attempt to revamp drug price regulation in the country, while strengthening implementation and market monitoring, the government is set to restructure the regulator, National Pharmaceutical Pricing…
Late-stage breast cancer cured by ‘immunotherapy’
A woman with an aggressive form of breast cancer which defied chemotherapy and spread to other organs, was cured with an experimental treatment that triggered her immune system, researchers said.…
Will make cancer drug Fulphila in Bengaluru: Biocon CMD
In a major milestone for domestic company Biocon, the US Food and Drug Administration (USFDA) has approved its biosimilar Pegfilgrastim for cancer, co-developed with Mylan. Pegfilgrastim (Fulphila) will represent a…
Modicare cut prices around 15-20% from CGHS for medical services
The Indian government-sponsored scheme “National Health Protection Scheme (NHPS)”, known as Modicare will cover the new 1,354 fixed rate packages which are around 15-20% lower from the prices set by…
Soon a text message will be enough to spot fake medicines
It’s like impossible for a common man to recognize the medicine is fake or original. But soon that’s impossible work will be changed to possible and without any medical knowledge.…
Appellant got extra time from the DTAB Panel On banned FDCs!!
DTAB’s sub-committee has been examining the case related to the ban on 300-plus fixed-dose combination (FDC) drugs and extended the time limit to make submission of information on these banned…
